Asensus Surgical vs Intuitive Surgical Which Is Stronger?

Asensus Surgical and Intuitive Surgical are two prominent players in the rapidly growing robotic surgery market. Asensus Surgical, formerly known as TransEnterix, is a medical device company known for its innovative Senhance Surgical System, while Intuitive Surgical is the pioneer behind the widely-used da Vinci Surgical System. Both companies have seen significant growth in their stock prices in recent years, with investors closely monitoring their performance and market share in the evolving field of robotic-assisted surgery.

Asensus Surgical or Intuitive Surgical?

When comparing Asensus Surgical and Intuitive Surgical, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Asensus Surgical and Intuitive Surgical.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Asensus Surgical has a dividend yield of -%, while Intuitive Surgical has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Asensus Surgical reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, Intuitive Surgical reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.36%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Asensus Surgical P/E ratio at -1.13 and Intuitive Surgical's P/E ratio at 87.31. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Asensus Surgical P/B ratio is -8.36 while Intuitive Surgical's P/B ratio is 12.57.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Asensus Surgical has seen a 5-year revenue growth of -0.98%, while Intuitive Surgical's is 0.86%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Asensus Surgical's ROE at -406.97% and Intuitive Surgical's ROE at 15.59%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $0.35 for Asensus Surgical and $548.21 for Intuitive Surgical. Over the past year, Asensus Surgical's prices ranged from $0.17 to $0.40, with a yearly change of 136.27%. Intuitive Surgical's prices fluctuated between $308.58 and $556.23, with a yearly change of 80.25%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.